Carregant...
Angiotensin II Administration in Patients With COVID-19 Shock
To understand the hemodynamic effect of angiotensin II as a vasopressor in patients with shock secondary to COVID-19 infection. METHODS: A retrospective analysis was performed on all patients at a single center with COVID-19 infection and shock who were treated with angiotensin II. The hemodynamic r...
Guardat en:
| Publicat a: | Crit Pathw Cardiol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Lippincott Williams & Wilkins
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8132546/ https://ncbi.nlm.nih.gov/pubmed/33031192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HPC.0000000000000246 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|